Syneos Health completed the acquisition of RxDataScience for $62m.

Syneos Health, a fully integrated biopharmaceutical solutions organization, completed the acquisition of RxDataScience, a healthcare-focused data analytics, data management and Artificial Intelligence company, for $62m. “This acquisition boosts our ability to deliver strategic insights and technology-enabled solutions that address our customers’ most complex data challenges. We are thrilled to welcome the RxDataScience team to the Syneos Health family. Combining our end-to-end services and deep behavioral and therapeutic expertise with their AI and data-science capabilities will generate customer strategies to accelerate product development and time to market,” Alistair Macdonald, Syneos Health CEO.